FR806M - - Google Patents

Info

Publication number
FR806M
FR806M FR803638A FR803638A FR806M FR 806 M FR806 M FR 806M FR 803638 A FR803638 A FR 803638A FR 803638 A FR803638 A FR 803638A FR 806 M FR806 M FR 806M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR803638A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR803638A priority Critical patent/FR806M/fr
Application granted granted Critical
Publication of FR806M publication Critical patent/FR806M/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
FR803638A 1960-08-31 1960-08-31 Active FR806M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR803638A FR806M (fr) 1960-08-31 1960-08-31

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR803638A FR806M (fr) 1960-08-31 1960-08-31

Publications (1)

Publication Number Publication Date
FR806M true FR806M (fr) 1960-09-18

Family

ID=88244329

Family Applications (1)

Application Number Title Priority Date Filing Date
FR803638A Active FR806M (fr) 1960-08-31 1960-08-31

Country Status (1)

Country Link
FR (1) FR806M (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993024124A1 (fr) * 1992-05-26 1993-12-09 Smithkline Beecham Plc Compositions a base d'inhibiteurs de recepteur h2 a l'histamine et de complexes echangeurs cationiques
US5334378A (en) * 1992-04-02 1994-08-02 Rohto Pharmaceutical Co., Ltd. Pharmaceutical formulation in the form of aqueous suspension

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5334378A (en) * 1992-04-02 1994-08-02 Rohto Pharmaceutical Co., Ltd. Pharmaceutical formulation in the form of aqueous suspension
WO1993024124A1 (fr) * 1992-05-26 1993-12-09 Smithkline Beecham Plc Compositions a base d'inhibiteurs de recepteur h2 a l'histamine et de complexes echangeurs cationiques

Similar Documents

Publication Publication Date Title
FR1310106A (fr)
JPS366305B1 (fr)
IT649598A (fr)
FI42221B (fr)
FI42953B (fr)
DE1438454A1 (fr)
DE1422286C2 (fr)
DE1153142C2 (fr)
FR1231773A (fr)
FI44422B (fr)
FR1229287A (fr)
FR1228567A (fr)
DE1131416C2 (fr)
IT649412A (fr)
CS99924B5 (fr)
BE608325A (fr)
NL133843C (fr)
LU39734A1 (fr)
CH1395561A4 (fr)
BE644128A (fr)
BE615140A (fr)
BE610628A (fr)
BE606744A (fr)
BE609856A (fr)
NL137338C (fr)